[(2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-[[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-2-yl]methyl hydrogen sulfate

Term ID

CHEBI:151473

Synonyms

2-acetamido-2-deoxy-6-O-sulfo-beta-D-gluco-hexopyranosyl-(1->6)-D-galacto-hexopyranose
GlcNAc6S(b1-6)Gal

Definition

References

glygen:G48252ZN
glytoucan:G48252ZN

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from [(2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-[[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-2-yl]methyl hydrogen sulfate

Phenotype where environments contain [(2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-[[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-2-yl]methyl hydrogen sulfate

Phenotype modified by environments containing [(2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-[[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-2-yl]methyl hydrogen sulfate

Phenotype affecting [(2R,3S,4R,5R,6R)-5-Acetamido-3,4-dihydroxy-6-[[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy]oxan-2-yl]methyl hydrogen sulfate

Human Disease Model